Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Advanced Course on Early Drug Development 2024: Hong Kong SAR

Session 4 - The Academia and the Industry Perspective: Strenghts and challenges in bringing Phase I studies to region

The Academic perspective

Date

02 Feb 2024

Session

Session 4 - The Academia and the Industry Perspective: Strenghts and challenges in bringing Phase I studies to region

Topics

Translational Research;  Fundamentals of Cancer Care Organisation;  Cancer Care Equity Principles and Health Economics

Tumour Site

Presenters

Brigette Ma, HKSAR CN

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

The Industry perspective

Presenter: Ezogelin Gruyters, US

Session: Session 4 - The Academia and the Industry Perspective: Strenghts and challenges in bringing Phase I studies to region

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.